Potential Biomarkers for Ovarian Cancer

Abstract

Get full access to this article

View all access options for this article.

References

Reid

Permuth

Sellers

. Epidemiology of ovarian cancer: a review. Cancer Biol Med. 2017;14(1):9–32.

Wei

Sun

. Clinical outcome and prognostic factors of patients with early stage epithelial ovarian cancer. Oncotarget. 2017;8(14):23862–23870.

Wang

Zhang

Wang

. Expression of Sam68 correlates with cell proliferation and survival in epithelial ovarian cancer. Reprod Sci. 2017;24(1):97–108.

Samtani

Sharma

Garg

. Effects of endocrine-disrupting chemicals and epigenetic modifications in ovarian cancer: a review. Reprod Sci. 2018;25(1):7–18.

Jie

Yao

Zhang

Mingyan

. Slug is associated with tumor metastasis and angiogenesis in ovarian cancer. Reprod Sci. 2017;24(2):291–299.

Kwon

Godwin

. Regulation of HGF and c-MET interaction in normal ovary and ovarian cancer. Reprod Sci. 2017;24(4):494–501.

Zhou

Han

Zhou

. BTG3 overexpression suppresses the proliferation and invasion in epithelial ovarian cancer cell by regulating AKT/GSK3β/β-catenin signaling. Reprod Sci. 2017;24(10):1462–1468.

Yildirim

Kocal

Isik

. Ubiquitin-proteasome axis, especially ubiquitin-specific protease-17 (USP17) gene family, is a potential target for epithelial-mesenchymal transition in high-grade serous ovarian cancer [Published online]. Reprod Sci. 2018:1933719118799189. doi:10.1177/1933719118799189

Záveský

Jandáková

Weinberger

. Ascites-derived extracellular microRNAs as potential biomarkers for ovarian cancer. Reprod Sci. 2019;26(4):510–522.